Skip to main content
Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
21.07
+0.09 (0.43%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Sarepta Therapeutics Revenue

In the year 2025, Sarepta Therapeutics had annual revenue of $2.20B with 15.58% growth. Sarepta Therapeutics had revenue of $442.93M in the quarter ending December 31, 2025, a decrease of -32.73%.

Revenue (ttm)
$2.20B
Revenue Growth
+15.58%
P/S Ratio
1.01
Revenue / Employee
$2,632,619
Employees
835
Market Cap
2.21B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.20B296.26M15.58%
Dec 31, 20241.90B658.64M52.97%
Dec 31, 20231.24B310.32M33.26%
Dec 31, 2022933.01M231.13M32.93%
Dec 31, 2021701.89M161.79M29.96%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ultragenyx Pharmaceutical 673.00M
Aurinia Pharmaceuticals 283.06M
Adaptive Biotechnologies 276.98M
Stoke Therapeutics 184.42M
Zymeworks 105.97M
Ascentage Pharma Group International 82.08M
Mesoblast 65.38M
Ocular Therapeutix 51.95M
Revenue Rankings

SRPT News

More News